methyl 6-azido-2,3,5-tri-O-benzoyl-6-deoxy-α,β-D-glucofuranoside | 214134-56-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 6-azido-2,3,5-tri-O-benzoyl-6-deoxy-α,β-D-glucofuranoside
• CAS: 214134-56-2
• 化学式: C₂₈H₂₅N₃O₈
• 分子量: 531.522
• InChiKey: WGSGCJQNCBKHPQ-VBOBNGRMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.34
• 重原子数：
  39.0
• 可旋转键数：
  10.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  146.12
• 氢给体数：
  0.0
• 氢受体数：
  9.0

反应信息

• 作为反应物：
  描述：

  methyl 6-azido-2,3,5-tri-O-benzoyl-6-deoxy-α,β-D-glucofuranoside 在 三氟甲磺酸三甲基硅酯 、 硫酸 、 氨 、 六甲基二硅氮烷 作用下， 以 二氯甲烷 为溶剂， 反应 52.5h， 生成 4-Amino-7-[(2R,3R,4R,5R)-5-((R)-2-azido-1-hydroxy-ethyl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-6-bromo-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
  参考文献：
  名称：

  Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines

  摘要：

  7-(6-amino-6-deoxy-beta-D-glucofuranosyl)-5-cyanopyrrolo[2,3-d]pyrimidine (22) and 7-(3-amino-methyl-3-deoxy-beta-D-allofuranosyl)-5-cyanopyrrolo [2,3-d]pyrimidine (28) were synthesized by sequentially coupling silylated 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine with the corresponding protected sugars 9 and 17, followed by deblocking and catalytic hydrogenation. Conversion of the 5-nitrile in 22 and 28 into a carboxamide gave the corresponding sangivamycin derivatives 23 and 29. Whereas 5'-aminomethyl nucleosides 22 and 23 inhibited the growth of four different human tumor cell lines at mu M concentrations, the 3'-aminomethyl analogs 28 and 29 were much less active against these cells. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(98)00098-6
• 作为产物：
  描述：

  O3,O5-dibenzoyl-O1,O2-isopropylidene-O6-(toluene-4-sulfonyl)-α-D-glucofuranose 在 叠氮化锂 、 碘 作用下， 以 吡啶 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 29.0h， 生成 methyl 6-azido-2,3,5-tri-O-benzoyl-6-deoxy-α,β-D-glucofuranoside
  参考文献：
  名称：

  Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines

  摘要：

  7-(6-amino-6-deoxy-beta-D-glucofuranosyl)-5-cyanopyrrolo[2,3-d]pyrimidine (22) and 7-(3-amino-methyl-3-deoxy-beta-D-allofuranosyl)-5-cyanopyrrolo [2,3-d]pyrimidine (28) were synthesized by sequentially coupling silylated 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine with the corresponding protected sugars 9 and 17, followed by deblocking and catalytic hydrogenation. Conversion of the 5-nitrile in 22 and 28 into a carboxamide gave the corresponding sangivamycin derivatives 23 and 29. Whereas 5'-aminomethyl nucleosides 22 and 23 inhibited the growth of four different human tumor cell lines at mu M concentrations, the 3'-aminomethyl analogs 28 and 29 were much less active against these cells. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(98)00098-6